Medibio Technology Honored with Two Presentations at Mayo Clinic Convergence Neuroscience 2018

Sydney, Australia and Minneapolis, MN USA – 8 October 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, is happy to announce that two clinical abstracts by Dr. Archie Defillo et al. have been [...]

2018-10-07T19:31:02-05:00 October 7th, 2018|

Medibio Releases Corporate Health Product, ilumen™

Sydney, Australia and Minneapolis, MN USA – 3 October 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, today announced the release of ilumen™, its product and platform for corporate customers. ilumen™ is a [...]

2019-03-13T14:01:41-05:00 October 3rd, 2018|

Medibio Named Finalist for Prestigious Optus My Business Award

The awards are the longest-standing business awards program in Australia, identifying and acknowledging the achievements of Australia’s best business operators. October 1, 2018 | By Medibio Team Sydney, Australia and Minneapolis, MN USA – ​Oct. 01, 2018: Medibio Limited [...]

2018-10-03T13:36:59-05:00 October 1st, 2018|